The prevalence of obesity continues to rise around the world, driving up the need for
effective and durable treatments. The field of metabolic/bariatric surgery has grown rapidly in …

Background Endoscopic sleeve gastroplasty (ESG) is an endolumenal, organ-sparing
therapy for obesity, with wide global adoption. We aimed to explore the efficacy and safety of …

Background & Aims Weight loss via lifestyle intervention remains the mainstay of treatment
for nonalcoholic fatty liver disease (NAFLD). Endoscopic bariatric and metabolic therapies …

Background And Aims The growing burden of obesity as a chronic disease necessitates a
multifaceted approach to management. There has been an increase in the number of …

Background and Aims Nonalcoholic fatty liver disease (NAFLD) is the most common cause
of chronic liver disease in the United States and is closely associated with obesity and …

Background and Aims Endoscopic bariatric therapies are less-invasive alternatives to
bariatric surgery, and endoscopic gastroplasty (ESG) represents the latest evolution. This …

Simple Summary With the rapid advancements of medical technologies and patients' higher
expectations for precision diagnostic and surgical outcomes, gastroscopy has been …

This systematic review and meta-analysis aimed to determine the short-and medium-term
weight loss outcomes and comorbidity resolution following endoscopic sleeve gastroplasty …

Metabolic and bariatric surgery (MBS) is widely considered the most effective option for
treating obesity, a chronic, relapsing, and progressive disease. Recently, the American …

Introduction The prevalence of obesity has increased exponentially in recent decades, being
one of the diseases that most affects global health. It is a chronic disease associated with …